These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 15952201)

  • 21. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].
    Hernández Faraco A; Céspedes G; Trejo E
    Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
    Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
    Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.
    Wolfsberger S; Doostkam S; Boecher-Schwarz HG; Roessler K; van Trotsenburg M; Hainfellner JA; Knosp E
    Neurosurg Rev; 2004 Oct; 27(4):238-45. PubMed ID: 15168138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse.
    Tao Y; Liang G; Li Z; Wang Y; Wu A; Wang H; Lu Y; Liu Z; Hu G
    Br J Neurosurg; 2012 Oct; 26(5):700-4. PubMed ID: 22616825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
    Devaprasath A; Chacko G
    Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas.
    Barresi V; Alafaci C; Caffo M; Barresi G; Tuccari G
    Pathol Res Pract; 2012 Jun; 208(6):350-5. PubMed ID: 22494536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
    Tsuyuguchi N
    Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caveolin-1 in meningiomas: expression and clinico-pathological correlations.
    Barresi V; Cerasoli S; Paioli G; Vitarelli E; Giuffrè G; Guiducci G; Tuccari G; Barresi G
    Acta Neuropathol; 2006 Nov; 112(5):617-26. PubMed ID: 16850311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
    Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
    Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome.
    Abramovich CM; Prayson RA
    Am J Clin Pathol; 2000 Jul; 114(1):84-92. PubMed ID: 10884803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can recurrence of meningiomas be predicted?
    Kalala JP; Benoit D; De Ridder L
    Anticancer Res; 2004; 24(4):2319-24. PubMed ID: 15330178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and histological features of multiple meningiomas compared with solitary meningiomas.
    Huang H; Buhl R; Hugo HH; Mehdorn HM
    Neurol Res; 2005 Apr; 27(3):324-32. PubMed ID: 15845217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100A5: a marker of recurrence in WHO grade I meningiomas.
    Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
    Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
    Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
    Tang Y; Dundamadappa SK; Thangasamy S; Flood T; Moser R; Smith T; Cauley K; Takhtani D
    AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.
    Takei H; Buckleair LW; Powell SZ
    Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
    Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of cathepsin D in meningiomas.
    Castilla EA; Prayson RA; Abramovich CM; Cohen ML
    Am J Clin Pathol; 2003 Jan; 119(1):123-8. PubMed ID: 12520707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.